Since Moesin is a well-established oncogene [5, 6] and FBXW2 is a putative tumor suppressor [14, 15, 17–19], we sought to determine whether FBXW2 regulates breast cancer progression through controlling the expression level of Moesin. This evidence concerns the gene MSN and breast carcinoma.